Story perspectives

HHS Temporarily Allows Compounding Six Unapproved Peptides

By Drooid · Oct 28, 2026 · How we work

Read the story

Story summary

Summary

U.S. Health Secretary Robert F. Kennedy Jr. issued a temporary policy permitting pharmacies and physicians to compound six unapproved peptides.
HHS will not enforce FDA rules if pharmacies certify peptide purity, identity and report side effects.
The permitted peptides are BPC-157, TB-500, epitalon, KPV, MOTS-c and Semax.
Critics like Public Citizen’s Robert Steinbrook called the move reckless, while analysts project a $2-$3 billion market.

1 of 1

U.S. Health Secretary Robert F. Kennedy Jr. issued a temporary policy permitting pharmacies and physicians to compound six unapproved peptides.
HHS will not enforce FDA rules if pharmacies certify peptide purity, identity and report side effects.
The permitted peptides are BPC-157, TB-500, epitalon, KPV, MOTS-c and Semax.
Critics like Public Citizen’s Robert Steinbrook called the move reckless, while analysts project a $2-$3 billion market.